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Abstract
Problem: Widespread opioid misuse has led to the opioid epidemic that claims 130 deaths
per day due to an opioid overdose (CDC, 2018). The opioid epidemic has plagued the
United States for three decades and has been considered a public health emergency since
2017 (HHS, 2017). Rural communities are disproportionately affected by this problem and
in 2014, the rate of opioid overdose deaths was 45% higher in rural communities
(SAMHSA, 2018).
Context: Medication-assisted treatment (MAT) is considered the most effective treatment
for opioid dependence because it incorporates medication management and
biopsychosocial supports (Jones et al., 2018). Retention in a MAT program is predictive
of better health outcomes (Timko et al., 2016). However, there is a gap between opioid
dependence treatment need and access to MAT services in rural communities due to
limited resources (SAMHSA, 2018). The context for this project, within the particular
setting, is based upon the gap analysis that identified limited access and a waiting list for
MAT services at a community-based substance use disorder and recovery organization,
Granite Wellness, within a rural Northern California community.
Proposed Intervention: The proposed intervention is the expansion of MAT services at
Granite Wellness.
Proposed Outcome Measures: The project will evaluate the following outcome measures:
the number of patients admitted to MAT services, the 3-month treatment retention rate,
patient satisfaction, and staff satisfaction.
Problem Description
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Misuse of prescription and non-prescription opioids began in the 1990s (HHS,
2019). Several events preceded and contributed to the eventual widespread misuse of
opioids. Firstly, two small retrospective studies that were published in the 1980s
reassured medical providers that it was safe to prescribe opioids more frequently (Jones
et al., 2018). Secondly, pharmaceutical companies also aggressively marketed opioids as
non-addictive (Jones et al., 2018). Thirdly, there was an increased emphasis on treating pain
thoroughly when pain was added as the fifth vital sign (Scalpel, 2016). As a result, medical
professionals began prescribing opioids more frequently and there was an increase in the
number of people who were opioid-dependent (Jones et al., 2018). This population began to
use illicit opioids more frequently if they were unable to get a sufficient opioid prescription
(CDC, 2018). Consequently, in 2010, an increase in heroin overdose deaths was observed
(CDC, 2018). Then, in 2013, an increase in overdose deaths due to synthetic opioids, particularly
fentanyl, was observed (CDC, 2018).
Opioid use disorder (OUD) increases an individual’s morbidity and mortality (Hser et al.,
2017). There is also a significant societal impact related to “disease transmission, crime and law
enforcement costs, family distress, lost productivity, and increased health care utilization”
(Timko, Schultz, Cucciare, Vittorio, & Garrison-Diehn, 2016, p. 2). In 2015, it was estimated
that the total economic burden of the opioid crisis was $504 billion (Hagemeier, 2018). In the US
in 2016, there were 64,000 deaths due to drug overdoses, of which 42,000 were due to opioids
(Jones et al., 2018). The U.S. Department of Health and Human Services (HHS) classified the
opioid epidemic as a public health emergency in 2017 (HHS, 2017).
In response to this public health emergency, there were efforts to establish new pain
management guidelines and to develop new pain management treatment modalities with a lower
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abuse potential. The Drug Addiction Treatment Act of 2000 (DATA 2000) established a waiver
that physicians could apply for in order to prescribe medications for the treatment of opioid
dependence (Jones et al., 2018). Initially, physicians were only able to treat 30 patients,
however, in 2006, they were able to apply for an increase to 100 patients after the first year of
the waiver (Jones et al., 2018). Buprenorphine and the combination of buprenorphine plus
naloxone were FDA-approved in 2002 which allowed waivered physicians to prescribe them for
the treatment of opioid dependence (Jones et al., 2018). The Comprehensive Addiction and
Recovery Act of 2016 (CARA) allowed NPs and PAs to apply for a buprenorphine waiver after
completing 24 hours of training (SAMHSA, 2016).
Treatment programs that incorporate both pharmacotherapy and biopsychosocial
interventions have proven to be the most effective treatment for opioid dependence (Jones et al.,
2018). Medication-assisted treatment (MAT) is the preferred treatment delivery method because
it incorporates medication, behavioral therapy, and psychosocial supports. It has been shown that
retention in a MAT program correlates with better patient outcomes (Timko et al., 2016).
According to SAMSHA, MAT programs have been shown to improve patient survival, increase
retention in treatment, decrease illicit opiate use, decrease criminal activity, increase ability to
secure and maintain employment, improve birth outcome for moms with OUD, decrease risk of
contracting HIV and Hep C, and decrease risk of relapse (SAMHSA, 2015).
This project will be implemented within a community-based substance use and recovery
organization called Granite Wellness, located in Nevada County, a rural Northern California
community. The population for the project is under-served, rural residents with opioid use
disorder.
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This problem relates to the setting for the project because substance abuse is assumed to
be an urban problem, but in 2014, the rate of opioid overdose deaths was 45% higher in rural
areas compared to urban areas (SAMHSA, 2018). Furthermore, due to limited resources in rural
communities, residents are underserved when it comes to substance use disorder treatment
(SAMHSA, 2018). Therefore, there is a need for the project, the expansion of MAT services at
Granite Wellness, in order to provide the necessary treatment to address the high prevalence of
opioid use disorder within this underserved, rural community. Currently, there is also a waiting
list for MAT services at Granite Wellness because the need is greater than the available access.
Available Knowledge
The PICOT question is, in opioid use disorder (P), how does MAT (I) compared to
standard treatment (C) affect treatment retention (O) within 12 months (T)? The summary of
evidence is organized in an evaluation table in Figure 1. of Appendix A.
Substance use disorders (SUD) are relapsing conditions that result in high utilization of
various healthcare resources. Painter et al. (2018) looked at the inpatient utilization of patients
with SUD, in order to determine effective, lower-cost treatment options. They performed a
retrospective chart review of the Veterans Health Administration national database focusing on
patients with SUD, patients with co-occurring SUD and mental illness (MI), and patients with
co-occurring SUD and serious mental illness (SMI), and their utilization of inpatient services.
They reported that SUD/SMI and SUD/MI patients were higher utilizers than SUD patients.
They also determined that patients with SUD alone primarily utilized inpatient medical services,
patients with SUD/SMI primarily utilized inpatient psychiatric services, and patients with
SUD/MI utilized medical, psychiatric, and substance-related inpatient services. Based upon these
findings, they recommended coordination of outpatient medical, psychiatric and SUD services,
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and case management in order to comprehensively treat these patients and reduce their use of
hospital services. This article is rated Level II and good quality according to the Johns Hopkins
Nursing Evidence-Based Practice Appendix E Research Evidence Appraisal.
The Nickasch, Lander, Marshalek, Dix & Sullivan (2017) article was a retrospective
chart review to determine if the delivery format of group-based MAT, face-to-face versus
telepsychiatry, had an impact on additional substance use, average time to achieve 30 and 90
consecutive days of abstinence, and treatment retention rates at 90 and 365 days. The medical
records review consisted of 100 patients in the MAT program under the care of the same
psychiatrist and who received medication management either face-to-face or via video
conference. Both groups also received face-to-face group therapy with the same structure and
goals, but with different therapists. The researchers found no statistical difference between the
face-to-face and telepsychiatry groups regarding any of the outcome measures. However, with a
p-value of 0.09, the telepsychiatry tended toward significance in achieving abstinence more
quickly than the face-to-face group. The authors attempted to control for confounding by limiting
patients to those under the care of the same physician which resulted in a small sample size and
low statistical power. This article showed that when MAT is combined with face-to-face group
therapy, the medication management can be delivered either face-to-face or via video
conference, without having an impact on additional substance use, average time to achieve
abstinence, or treatment retention. Although this study did not have a large enough sample size
or enough statistical power to show statistical significance, it is clinically significant and can
guide practice. The article is rated Level II and good quality according to the Johns Hopkins
Nursing Evidence-Based Practice Appendix E Research Evidence Appraisal.
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The Hewell, Vasquez & Rivkin (2017) article was a qualitative study that aimed to
explore patient perceptions about buprenorphine and MAT in order to illuminate barriers to
treatment access and utilization, and to better inform health policy. The researchers gathered data
in 2 focus groups and semi-structured interviews of participants who had either been enrolled in
or were currently enrolled in a MAT program. Grounded theory was used to code the data. The
researchers utilized an outside data analysis expert in order to reduce any researcher biases. The
researchers identified and described the following factors and their influence on seeking,
participating and completing treatment: individual and systemic factors, models of addiction and
MAT, barriers and facilitators, and the road to recovery. Understanding patient perceptions about
MAT can guide changes in individual provider-patient interactions, treatment delivery, and
health policy to facilitate and support long-term recovery. All participants agreed that MAT
should not be solely medication management, rather, it should incorporate some supportive
treatment. The study is limited by its small sample size that lacked diversity; therefore, the
findings cannot be generalized. The researchers reported that even though they had a small
sample size, they were able to gather enough data to answer all of the research questions and
they reached data saturation. One of the main benefits of this study is that it outlines patient
perceptions on treatment options for the very important issue of opioid addiction that has a major
impact on the individual and the greater community. The article is rated Level V & good quality
Johns Hopkins Nursing Evidence-Based Practice Appendix E & F.
The Truong et al. (2019) article was a qualitative study to identify treatment retention
barriers for individuals with OUD who participated in a combined MAT and peer-support
program. The researchers gathered data through in-depth, semi-structured individual interviews
with clients and staff, and focus group discussions with current and past clients. They identified
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that for individuals enrolled in a combined MAT and peer-support program, the barriers to
treatment retention, and long-term recovery as an extension, include cravings and withdrawal
symptoms, mental health issues, legal issues, stigma of medication, inflexible program
requirements and employment issues. Addressing these barriers can change practice by helping
to guide MAT protocols to make treatment more supportive. This study is limited by its small
sample size and the findings are not generalizable. Researchers interacted with the participants
prior to the study which may have resulted in some bias. A strength of this study is that both the
staff and the clients agreed on the primary challenges to treatment retention in a MAT program.
This article is rated as Level V & good quality according to the Johns Hopkins Nursing
Evidence-Based Practice Appendix E & F.
Rationale
One of the frameworks that underpins the project is the Health Belief Model (HBM). The
HBM states that people are likely to engage in a health behavior change if they believe they are
susceptible to a condition, the condition is severe, they can reduce the likelihood or severity of
the condition by acting, there are benefits to acting, and the perceived barriers can be overcome
(Glanz, Rimer, & Viswanath, 2015). An example of perceived susceptibility is: according to
National Safety Council “Injury Facts”, people are more likely to die from an opioid overdose
than from a motor vehicle accident (National Safety Council, 2019). An example of perceived
severity is: people with OUD have a higher risk of death (Hser et al., 2017). An example of
perceived threat is: according to the CDC, 130 Americans die every day from an opioid overdose
(CDC, 2018). An example of perceived benefits is: MAT is a proven, effective approach to treat
opioid use disorder that consists of medication and behavioral therapy (SAMHSA, 2015). An
example of perceived barriers is: many people with OUD report that they feel ashamed or
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undeserving of care (McElrath & Joseph, 2018). An example of a cues to action is: give MAT a
try even if other treatment options have not been effective because the MAT process approaches
treatment differently by getting to know the patient, his/her preferences and values. An example
of self-efficacy is: MAT programs advertise the positive health outcomes associated with
treatment to motivate people that they can achieve those outcomes by participating in the
treatment program as well.
Social Network Theory (SNT) is a theoretical framework that will also guide the project.
SNT has three components: network environment, position in a network, and the effect of
a networks structure and characteristics on performance (Glanz, Rimer, & Viswanath,
2015). The first component describes how an individual’s actions are based upon one’s network
environment; people tend to associate with people who are similar to them and that is called
homophily (Glanz, Rimer, & Viswanath, 2015). The second component describes how a
person’s position in a network influences his or her behavior (Glanz, Rimer, & Viswanath,
2015). The third component describes how networks have structure and how network
characteristics influence system performance (Glanz, Rimer, & Viswanath, 2015). This
framework describes how social networks, i.e. a MAT program, influences one’s health-related
behaviors, i.e. treatment retention. SNT predicts that an individual, surrounded by people in
recovery, is more likely to engage in a recovery program as a result of homophily and influence.
Specific Aims
The purpose of this project is to improve health outcomes for patients with opioid use
disorder in an underserved rural community in northern California by increasing access to
medication assisted therapy (MAT) and evaluating factors that affect treatment retention. The
AIM statement is: By January 2021, Granite Wellness Grass Valley Campus will expand and
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evaluate Nurse-Managed Community-based Medication Assisted Treatment Services for an
Underserved Rural Northern California Community to increase access to and retention in
treatment for opioid use disorder.
Methods
Context
Contextual elements that are considered important are the key stakeholders. They include
the opioid addicts, families/friends of the addicts, Granite Wellness employees, and the Nevada
County community. The opioid addict role in this issue is working through a chronic, relapsing
condition. The family/friend role in this issue is to provide support. The medical provider role is
to be willing and able to address addiction, to engage in continuing education, and to facilitate
the MAT program. The administrative and support staff role is to promote, support, and to
participate in the facilitation of the MAT program. The Nevada County community role is to
buy-in to MAT as an effective treatment for a serious public health problem and to provide
funding in support of the MAT program and its expansion.
Proposed Intervention
The DNP student will begin by meeting with key stakeholders at Granite Wellness to
understand the vision, mission and goals for the MAT program. The DNP student will evaluate
the MAT services at Granite Wellness as developed and implemented by a previous DNP
student. The initial evaluation will serve as baseline data and will assess: the current practices,
the number of patients admitted to the program, the 3-month treatment retention rate, patient
satisfaction surveys, and staff satisfaction surveys. The DNP student will schedule a follow-up
meeting with key stakeholders to present the baseline data findings. The DNP student will assist
in the expansion of MAT services as the buprenorphine waivered providers are able to increase
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their patient load from 30 to 100 patients, per the waiver regulations. The DNP student will assist
in writing new MAT protocols that account for the increased workflow. The DNP student will
evaluate the aforementioned outcome measures 3-months after the expansion of MAT services.
The DNP student will present the findings of this DNP project to the key stakeholders at Granite
Wellness.
There is a significant gap in the literature regarding MAT. In searching the databases,
there were some articles in CINAHL, PubMed, Scopus, PsycINFO, and Joanna Briggs. There are
opioid abuse and dependence treatment guidelines in Dynamed, but there are no specific
guidelines for MAT. There were no systematic reviews on MAT in Cochrane.
MAT is not a particularly new treatment concept, but it has become more well-known
because of the opioid epidemic. The demand for access to MAT programs has increased
substantially, but there is not a lot of research on the specifics of this treatment option,
particularly regarding delivery format. In fact, there are no standardized guidelines or protocols
for MAT programs; some programs are face-to-face, some are via telehealth, some are
individual-based, some are group-based, etc. It seems that the research on MAT programs cannot
keep up with the opioid epidemic. Rather than wait on large-scale studies to provide statistically
significant results and evidence-based guidelines, MAT programs are sprouting up based upon
clinically significant data and evolving in response to better meet the needs of their specific
patient populations. MAT programs are producing practice-based evidence that will lead to the
development of standardized, evidence-based practices.
As mentioned earlier, MAT increases retention in treatment and reduces opioid use,
risky behaviors and mortality (Jones, Campopiano, Baldwin, & McCance-Katz, 2015). There is a
significant gap between the need for opioid dependence treatment and access to MAT.
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Nationally, the gap was estimated to be 1 million people in 2012, and that estimate was based
upon every waivered physician maintaining a full patient load per their waiver capacity (Jones et
al., 2015).
Based upon the research, the gap analysis in Figure 2. of Appendix B, revealed that the
desired state is access to MAT within this rural Northern California community in order to
provide treatment for the high prevalence of opioid use disorder and improve health outcomes
within this rural population. The current state is limited access to and a wait list for MAT
services at Granite Wellness resulting in an underserved opioid-dependent population with a high
incidence of opioid overdose deaths. The action needed is to increase access to MAT at Granite
Wellness and to assess factors that facilitate treatment retention.
The GANTT chart is in Figure 3. of Appendix C. The DNP student will meet with the
DNP chair/clinical instructor in April 2020, during project implementation, and then in April to
May 2021. The DNP recruit a doctorally prepared University of San Francisco (USF) faculty
member as the second member of the committee in April 2020. The DNP student will maintain
communication with the second committee member in June 2020 and January to May 2021. The
DNP student will brief the MAT medical director and the Granite Wellness administration on the
project between May and June 2020, and then provide a debrief in January and May 2021. The
DNP student will brief the staff on the project during a staff meeting between May and June
2020 and the debrief will be provided in May 2021. The project will be implemented between
June 2020 and January 2021. The data will be compiled between November 2020 and January
2021. The data analysis will be performed between November 2020 and February 2021.
Recommendations will be made, based upon the data analysis, between February and May 2021.
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The SWOT chart is in Figure 4 of Appendix D. The main strengths of this project is that
MAT is the most effective treatment for opioid dependence (Jones et al., 2018). Another strength
of this project is that it aims to increase access to MAT services at Granite Wellness through the
expansion of a current program, rather than developing and implementing a new program. The
expansion of MAT services at Granite Wellness will bridge the gap between demand for and
access to opioid use disorder treatment in Nevada County, offer better opioid use disorder
management in Nevada County, and improve health outcomes for people with opioid use
disorder in Nevada County (Timko et al., 2016). Another strength of this project is that the
Granite Wellness administration is on board and has bought in to the expansion of MAT
services.
The main weakness of this project is getting and maintaining buy-in from the
buprenorphine-waivered providers. The waivered providers will be able to increase their patient
load from 30 to 100 patients per the waiver regulations; their willingness to take on and maintain
the increased workload will be a limiting factor in this project. Another weakness of this project
is that the support staff will also experience an increase in workload. The Granite Wellness
administration has approved the expansion of MAT services at the Grass Valley campus, but
there are no plans to expand the physical space so that may pose a limitation to the services that
are actually able to be provided. The final weakness to consider in this project is related to
addiction as a chronic, relapsing condition and, as a corollary, providers and staff working in
addiction medicine can experience strain and burnout.
The opportunity that this project offers is an effective means to address the opioid
epidemic. The expansion of MAT services at Granite Wellness will have a direct impact on this
public health issue within Nevada County, and over time, the downstream effects will be
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observed on the national level. The expansion of MAT services has the potential to improve
treatment retention rates by incorporating medication, behavioral therapy, and psychosocial
supports (Jones et al., 2018). MAT can improve treatment retention rates which have been shown
to correlate with better health outcomes (Timko et al., 2016). There is an opportunity for patient
and staff satisfaction with the expansion of MAT services as a result of the improved retention
rates and better health outcomes.
The threats to this project include patient buy-in. There is a stigma that people who are
enrolled in MAT are not truly in recovery because one drug (i.e. buprenorphine) is being taken in
the place of another (i.e. heroin). Stigma has been cited as one of the main barriers to both
treatment access and retention (McElrath & Joseph, 2018). With any treatment plan, there is a
risk that patients will be non-compliant. Although buprenorphine is considered to be “lessaddictive” as compared to methadone, there is still a risk of diversion. Lastly, there is a risk of
relapse which would pose a threat to the success of this project.
All in all, the strengths outweigh the weaknesses of this program. Based upon the SWOT
analysis completed in Figure 4. of Appendix D, the program is feasible.
The Work Breakdown Structure (WBS) Tree is in Figure 5. of Appendix E. The
expansion of MAT services at Granite Wellness will occur in five phases: initiation,
planning, execution, control and closeout.
During the initiation phase, a gap analysis will be completed based upon a
thorough literature review and a needs assessment specific to Granite Wellness in Grass
Valley. The DNP student will meet with key stakeholders at Granite Wellness to understand the
vision, mission and goals for the MAT program. The DNP student will evaluate the MAT
services at Granite Wellness as developed and implemented by a previous DNP student. The

THE EXPANSION AND EVALUATION OF MAT

15

initial evaluation will serve as baseline data and will assess: the current practices, the number of
patients admitted to the program, the 3-month treatment retention rate, patient satisfaction
surveys, and staff satisfaction surveys. A project charter will be developed and submitted to
the DNP chair for review. Upon approval, the project charter will be presented to Granite
Wellness stakeholders for their approval.
During the planning phase, the preliminary plan will be presented at a Granite
Wellness staff meeting. The project team will be formed. There will be a project team
kickoff meeting to present the preliminary plan and to get the team excited about the
upcoming phases of the project. The project plan will be developed and finalized. The
project plan will be submitted and approved by the DNP chair. Then, the project plan will
be submitted and approved by Granite Wellness stakeholders.
During the execution phase, there will be a project kickoff meeting to update all
stakeholders on the project plan. Current MAT protocols will be verified and validated.
The protocols will be updated, as needed, to align with the upcoming expansion. The data
management system capabilities will be tested to verify its ability to manage an increase
in data and to track data throughout this project for analysis. At this time, we will begin
to advertise locally about the upcoming expansion of MAT services at Granite Wellness.
In order to ease providers and staff in to this expansion, there will be a graduated
expansion that will begin by increasing each provider’s buprenorphine empanelment from
30 to 60 patients and then from 60 to 100 patients. Any initial “growing pains” that are
observed during the initial graduated expansion, will be troubleshooted prior to the
second graduated expansion. Additional training may need to be provided to the support
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staff in order to assist them through this expansion. At this time, we will be ready to go
live.
During the control phase, project management will take place. There will be
project status meetings. Risk management will be important especially because the
expansion of these services is intended to reduce, both short-term and long-term, risks
associated with opioid use disorder. The project management plan will be updated, as
needed.
During the closeout phase, data will be collected with a particular emphasis on the
number of patients admitted to the program, the treatment retention rate, patient
satisfaction surveys, and staff satisfaction surveys. Lessons learned will be documented.
Data will be presented to Granite Wellness stakeholders. The prospectus will be
submitted to the DNP chair. The final manuscript will be submitted to the DNP chair.
The proposed budget is in Figure 6. of Appendix F. The DNP student will work at
Granite Wellness 1 day/week for at least 6 months to assist in the expansion of MAT services
and to evaluate the outcome measures 3-months after the expansion of MAT services. The
estimated cost of those services is $75/hr., the average NP hourly rate in California x 192 hrs. =
$14,400 (American Association of Nurse Practitioners, 2020). The estimated cost of copies of
the satisfaction surveys and print outs from the electronic health record are $0.073/copy totaling
approximately $10.00.
The communication plan/matrix is in Figure 7. of Appendix G. For overall project
planning, the DNP student will consult the project chair monthly and as needed via zoom, email
and phone. For logistics, the DNP student will consult the project chair, MAT medical director &
Granite Wellness administration prior to, during and post-intervention via face-to-face meetings
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at Granite Wellness and email. The DNP student will give status updates to the project chair,
MAT medical director & Granite Wellness administration as needed via email, zoom and faceto-face. The DNP student will consult the project chair and Granite Wellness administration for
any materials needed between April and June 2020, via email, phone, face-to-face. The project
chair and Granite Wellness administration will be consulted to determine time, space, and
technology requirements for the intervention between April and June 2020, via email, phone, and
face-to-face.
Proposed Outcome Measures
This intervention will change practice because the expansion of MAT services at Granite
Wellness will increase access to the preferred treatment delivery system for opioid use disorder
and an increase in the treatment retention rate correlates to improved patient outcomes. The
proposed outcome measures are the number of patients admitted to MAT services, 3-month
treatment retention rate, patient satisfaction, and staff satisfaction. The effectiveness of this DNP
project will be observed by an increase in the number of patients admitted to MAT services, a
10% improvement in the 3-month treatment retention rate, and satisfactory answers on the
patient and staff surveys.
Proposed Analysis
Excel will be utilized to collect and analyze the baseline and post-intervention data.
Survey Monkey will be utilized to collect the pre and post satisfaction surveys.
Ethical Considerations
Patient privacy will be protected according to HIPAA policies. The project relates to the
Jesuit value of Cura Personalis or care of the whole person: mind, body, and spirit because the
premise of MAT is incorporating care of the whole person in to the treatment of the opioid use
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disorder. (Ctzejanda, 2019). The project relates to the ANA Code of Ethics Provision 3: The
nurse promotes, advocates for, and protects the rights, health, and safety of the patient because
the MAT program at Granite Wellness is managed by nurses who promote, advocate for, and
protect the rights, health and safety of the patients (American Nurses Association, 2015).
Discussion
Stigma has been identified as one of the main barriers to both treatment access and
retention (McElrath & Joseph, 2018). The MAT approach aims to provides supportive, nonjudgmental, patient-centered treatment with an emphasis on shared-decision making between the
medical provider and the patient so as to mitigate the effects of stigma.
There are patient and provider barriers when it comes to MAT. Patient barriers include,
but are not limited to, access to an available provider who is willing to prescribe, stigma as
mentioned above, and the cost of treatment (Jones et al., 2015). This intervention aims to expand
MAT services at Granite Wellness so that patients will have ready access to a provider who is
willing to prescribe. Granite Wellness provides MAT services to anyone with an opioid use
disorder regardless of their ability to pay to mitigate the cost of treatment as a barrier.
Provider barriers include, but are not limited to, confidence in treating addiction, lack of
professional and/or institutional support, and reimbursement issues (Jones et al., 2015). There is
a free 24-hrs online training on medication-assisted treatment to increase provider confidence in
treating addiction. The medical director at Granite Wellness provides mentorship and
professional support. The Granite Wellness administration offers institutional support of the
MAT program. Reimbursement issues are bigger than the scope of this project, unfortunately.
Conclusions

THE EXPANSION AND EVALUATION OF MAT

19

The opioid epidemic has had significant, negative implications on individuals, as well as
on society as a whole, within the United States. Medication-assisted treatment is widely accepted
as the most effective treatment for opioid dependence. Rural communities are disproportionately
affected by this problem and are underserved when it comes to treatment access. There is a
significant gap between opioid dependence treatment need in Nevada County and MAT access at
Granite Wellness. The potential short-term implications of this change in practice are increased
access to MAT at Granite Wellness and improved treatment retention rates for the rural residents
enrolled in MAT at Granite Wellness. The potential long-term implications of this change in
practice are better health outcomes for residents of Nevada County with opioid use disorder and,
on the macro level, an end to the opioid epidemic.
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Figure 1. Evaluation Table.
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Appendix B
Figure 2. Gap Analysis.
•

Desired
State:

•

•

Current
State:

•

•

Action
Needed:

•

Access to MAT within this rural Northern California
community in order to provide treatment for the high
prevalence of opioid use disorder and improve health
outcomes within this rural population.
Limited access to and a wait list for MAT services at
Granite Wellness resulting in an underserved opioiddependent population with a high incidence of opioid
overdose deaths.
Increase access to MAT at Granite Wellness and to assess
factors that facilitate treatment retention.
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Figure 3. GANTT Chart.
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Appendix D
Figure 4. SWOT Analysis.

STRENGTHS

WEAKNESSES

MAT is the most effective treatment for
opioid dependence.
Increased access to MAT services at Granite
Wellness through the expansion of a current
practice.
àbridge the gap between demand for and
access to opioid use disorder treatment in
Nevada County.
àbetter opioid use disorder management in
Nevada County.
à improved health outcomes for people with
opioid use disorder in Nevada County.
Program buy-in by the Granite Wellness
administration.

Ability to get buprenorphine waivered
providers buy-in to the increased workload in
order to increase patient access to treatment.
Increased responsibility for support staff.
Physical space limitations.
Addiction medicine provider and staff strain
and burnout.

OPPORTUNITIES

THREATS

The expansion of these services is relevant to
addressing the opioid epidemic.
MAT can:
àimprove treatment retention rates.
àimprove health outcomes.
àimprove patient satisfaction.
àimprove staff satisfaction.

Program buy-in by patients with opioid use
disorder.
Stigma that enrollment in MAT services
means that they are not clean and sober.
Treatment non-compliance.
Diversion of buprenorphine.
Relapse.
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Appendix E
Figure 5. Work Breakdown Structure.
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Appendix F
Figure 6. Proposed Budget.
Item

Time

Cost

Totals

DNP student
at Granite
Wellness

1 day per
week x 6
months

Assist in the expansion of MAT services
and evaluate the outcome measures 3months after the expansion of MAT
services.

$75/hr. x
192 hrs. =
$14,400.

Supplies

1 day per
week x 6
months

Copies of satisfaction surveys and print
outs from electronic health record:
$0.073/copy.

$10.00
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Appendix G
Figure 7. Communication Plan/Matrix.
Information

Consulted

When

How

Responsible

Overall Project
Planning

DNP Chair

Monthly and
as needed

Zoom,
email,
phone

DNP student

Intervention
Planning
(Logistics)

DNP Chair, MAT
Medical Director &
Granite Wellness
Administration

Meeting prior
to, during and
post
intervention

DNP student

Status Updates

DNP Chair, MAT
Medical Director &
Granite Wellness
Administration

As needed

Face-toface at
Granite
Wellness,
email
Email,
zoom, faceto-face

Intervention
Materials

DNP Chair &
Granite Wellness
Administration

April to June
2020

Email,
DNP student
phone, faceto-face

May 2020

Email,
Granite
phone, face- Wellness
to-face

Time, Space,
DNP Chair &
Technology
Granite Wellness
Requirements for Administration
Intervention

DNP student

